FDA Poised To Require More Rigorous Study Of Drug Use In Pregnancy
Executive Summary
With new guidance expected, internal comparison groups, better protocols and potential generic industry involvement are some features that appear likely for the next generation of post-marketing requirements to assess drug safety in pregnancy.